About
AAV-delivered opsin
Areas of Focus
Categories
Virus TechnologyGene Therapy, RNA & Peptide TherapySouthwestern U.S.
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
144
By Phase
PHASE2: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 4ACTIVE_NOT_RECRUITING: 2RECRUITING: 1ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06805474Lead Sponsor
A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
N/ARecruiting
30 participants
Started: Jan 28, 2025 · Completed: May 27, 2025
NCT06162585Lead Sponsor
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
N/AActive, not recruiting
18 participants
Started: Dec 8, 2023 · Completed: Sep 30, 2027
NCT06048185Lead Sponsor
Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT Study
N/AActive, not recruiting
6 participants
Started: Oct 19, 2023 · Completed: Jul 31, 2027
NCT05921162Lead Sponsor
A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection
N/AEnrolling by invitation
11 participants
Started: Jul 14, 2023 · Completed: May 31, 2025
NCT05820100Lead Sponsor
Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT
N/ACompleted
35 participants
Started: Apr 25, 2023 · Completed: Oct 17, 2023
Funding History (1)
D
Jul 22, 2020
Locations (1)
Headquarters
Dallas, TX, United States
Map
Loading map...